Subscribe
Friday, September 25, 2026
22.4 C
Bengaluru
type here...
Subscribe

Anup Soans

Reach out to Anup Soans: anupsoans@medicinman.net.
facebooklinkedintwitter

What’s Killing Patients? Cancer or Rigged Drug Prices?

Ethics in Healthcare Anup Soans -
The disease is real. So is the markup. Confusing the two turns a treatable protocol into a financial death...

A Tale of Two Cities: Peptides and Prescriptions

MedicinMan Market Intelligence Anup Soans -
What our health choices reveal about education, access and inequality in India A cancelled “peptide party” in Bengaluru and a...

Trust Is Pharma’s Fulcrum: Are We Getting the Basics Right?

MedicinMan Market Intelligence Anup Soans -
MedicinMan Intelligent Insights When Air India CEO Tewolde Gebremariam addressed employees in September 2026, one instruction stood out: “If something...

The $1.5 Billion Question in Hyderabad: Orbicular, Peptides and the PE Re-Rating of Indian Complex Generics

MedicinMan Market Intelligence Anup Soans -
Private equity does not pay a billion-dollar multiple simply because a company describes itself as a “complex generics” player....

Medical Reps—Lessons From The West: The Old Model is Dead

MedicinMan Pharma Pulse Anup Soans -
The Core Conclusion The Western pharma industry is not simply bringing back traditional Medical Reps. It is redefining the role:...

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

Digital in Pharma Anup Soans -
How wearables, diagnostics, AI and continuous monitoring are moving healthcare from episodic treatment to continuous health management A forty-two-year-old woman...
spot_imgspot_img

RPG-Raghava and Lessons From a Decade of Indian Pharma M&A

Featured Article Anup Soans -
RPG Active Pharma’s agreement to acquire the API and intermediates business of Raghava Life Sciences for up to Rs...

Pharmacy of the World Pricing Paradox

Healthcare Ececutive Anup Soans -
India occupies an extraordinary position in global pharmaceuticals. It supplies around 20 per cent of the world’s generic medicines...

Why The Government Must Stop Playing Market Trader And Start Being The Sheriff

Featured Article Anup Soans -
India has two very different pharmaceutical regulators living inside the same government. Through the National Pharmaceutical Pricing Authority, or...

MedicinMan Pharma Pulse: August 2026

MedicinMan Pharma Pulse Anup Soans -
🚀 The Mega-Merger That Wasn't Early August saw the Financial Times report that AstraZeneca and Bristol Myers Squibb (BMS)...

GLP-1: When the Molecule Becomes a Commodity, What Becomes the Moat?

Featured Article Anup Soans -
STOP PRESS August 10, 2026: Regulatory Authorisation — The UK Medicines and Healthcare products Regulatory Agency (MHRA) officially approved/authorised orforglipron...

How To See Dr Reddy’s Nestle In The Wellness Shift

Exclusive Report Anup Soans -
GLP-1 medicines such as semaglutide and tirzepatide are changing how we treat diabetes and obesity. But their impact may...
Load more

MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More

Company

Headlines

What’s Killing Patients? Cancer or Rigged Drug Prices?

0
The disease is real. So is the markup. Confusing...

A Tale of Two Cities: Peptides and Prescriptions

0
What our health choices reveal about education, access and...

Trust Is Pharma’s Fulcrum: Are We Getting the Basics Right?

0
MedicinMan Intelligent Insights When Air India CEO Tewolde Gebremariam...

The $1.5 Billion Question in Hyderabad: Orbicular, Peptides and the PE Re-Rating of Indian Complex Generics

0
Private equity does not pay a billion-dollar multiple simply...

Newsletter

Get important news delivered directly to your inbox and stay connected!

Copyright © 2026 | Crafted by SlamDunk